摘要:
A novel crystalline organic acid salt of amlodipine having improved physiochemical properties, a preparation method thereof and a pharmaceutical composition comprising the same are provided.
摘要:
Disclosed are a novel organic acid salt of amlodipine, its preparation method, and a pharmaceutical composition containing the same as a therapeutically active ingredient.
摘要:
Disclosed are a novel organic acid salt of amlodipine with superb physicochemical properties, its preparation method, and a pharmaceutical composition containing the same as a therapeutically active ingredient.
摘要:
Disclosed are a novel organic acid salt of amlodipine, its preparation method, and a pharmaceutical composition containing as a therapeutically active ingredient the same.
摘要:
Disclosed are a novel organic acid salt of amlodipine, its preparation method, and a pharmaceutical composition containing the same as a therapeutically active ingredient.
摘要:
A 1,2,4-Triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.
摘要:
The present invention relates to a novel 1H-indole derivative having a structure of formula 1 and its pharmaceutically acceptable salts as a highly selective cyclooxygenase-2 inhibitor. Wherein, X, Y, and Q are defined in this specification respectively.
摘要:
The present invention relates to a novel 3,4-dihydro-1H-naphthalene derivative having a structure of formula 1 or formula 2, its pharmaceutically acceptable salts and their geometric isomers as a highly selective cyclooxygenase-2 inhibitor. Wherein, R1, R2, X, A and Q are defined in this specification respectively.
摘要:
A ferrous alloy for powder injection molding is provided. The ferrous alloy for powder injection molding includes iron (Fe) at 52.59-78.15 wt %, chromium (Cr) at 16.45-37.34 wt %, boron (B) at 3.42-7.76 wt %, silicon (Si) at 1.64-1.92 wt %, sulfur (S) at 0-0.21 wt %, carbon (C) at 0.16-0.18 wt %, and other inevitable impurities.
摘要:
The present invention relates to a novel 3,4-dihydro-1H-naphthalene derivative having a structure of formula 1 or formula 2, its pharmaceutically acceptable salts and their geometric isomers as a highly selective cyclooxygenase-2 inhibitor. Wherein R1, R2, X, A and Q are defined in this specification respectively.
摘要翻译:本发明涉及具有式1或式2结构的新型3,4-二氢-1H-萘衍生物,其药学上可接受的盐及其几何异构体作为高度选择性的环氧合酶-2抑制剂。在R 1, R 2,X,A和Q分别在本说明书中定义。